NET PROFIT (x1000 SEK)
EMPLOYEES
Edwards Lifesciences A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
5,961
|
7,734
|
7,146 |
| Total assets |
46,564
|
43,468
|
56,697 |
| Current assets |
46,497
|
0
|
0 |
| Current liabilities |
14,785
|
15,885
|
36,897 |
| Equity capital |
31,733
|
27,540
|
19,801 |
| - share capital |
744
|
748
|
688 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
68.1%
|
63.4%
|
34.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
314.5%
|
0%
|
0% |
| Return on equity (ROE) |
18.8%
|
28.1%
|
36.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.